(Reuters) - U.S. Food and Drug Administration had decided against approving generic versions of Norvasc other than an already launched generic version made by Mylan.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment